RT Journal Article
SR Electronic
T1 Extensive weight loss can reduce immune age by altering IgG N-glycosylation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.24.20077867
DO 10.1101/2020.04.24.20077867
A1 Greto, Valentina L
A1 Cvetko, Ana
A1 Štambuk, Tamara
A1 Dempster, Niall J
A1 Kifer, Domagoj
A1 Deriš, Helena
A1 Cindrić, Ana
A1 Vučković, Frano
A1 Falchi, Mario
A1 Gillies, Richard S
A1 Tomlinson, Jeremy W
A1 Gornik, Olga
A1 Sgromo, Bruno
A1 Spector, Tim D
A1 Menni, Cristina
A1 Geremia, Alessandra
A1 Arancibia- Cárcamo, Carolina V
A1 Lauc, Gordan
YR 2020
UL http://medrxiv.org/content/early/2020/04/29/2020.04.24.20077867.abstract
AB Background Obesity represents a global health threat, and is associated not only with exponentially increased cardiometabolic morbidity and mortality, but with adverse clinical outcomes in patients infected with SARS-CoV-2 as well. Enzymatic attachment of complex oligosaccharides to proteins (glycosylation) is highly responsive to numerous (patho)physiological conditions and ageing, which is perhaps best exemplified on IgG. The prospect of immune age reduction, by reverting induced glycosylation changes through metabolic intervention, opens many possibilities. Herein, we have investigated whether weight loss interventions affect inflammation- and ageing-related glycosylation alterations, in a longitudinal cohort of bariatric-surgery patients. To support potential findings, BMI-related glycosylation changes were monitored in a longitudinal TwinsUK cohort.Methods IgG and plasma N-glycans were chromatographically profiled in 37 obese patients, subjected to low-calorie diet and then to bariatric surgery, across multiple timepoints. Similarly, plasma glycome was analysed in 1,680 TwinsUK participants and longitudinally monitored during a 20-year follow-up.Findings Low-calorie diet induced marked increase in low branched and significant decrease in highly branched, more complex plasma N-glycans – the change opposite to the one typically observed in inflammatory conditions. Bariatric surgery resulted in extensive, gradual alterations in IgG glycome, that accompanied progressive weight loss during one year follow-up. We observed significant increase in digalactosylated and sialylated, and substantial decrease in agalactosylated and core fucosylated IgG glycans. In general, such IgG glycan profile is associated with a younger biological age and reflects enhanced anti-inflammatory IgG potential. The TwinsUK cohort replicated weight loss-associated agalactosylation decrease and digalactosylation increase, estimated through BMI decrease over a 20-year-period.Interpretation Altogether, these findings highlight that weight loss substantially affects both plasma and IgG N-glycosylation, resulting in improved biological and immune age.HIGHLIGHTSObesity is associated to circulating pro-inflammatory high branched N-glycans and IgG agalactosylationHigh branching of N-glycans from total plasma proteins decreases after 3-week low-calorie dietIgG galactosylation and sialylation increase after bariatric surgery-induced weight lossDecrease of BMI over time is associated with increased IgG galactosylation and improvement of biological ageCompeting Interest StatementGL declares that he is a founder and owner of Genos Glycoscience Ltd, which offers commercial service of glycomic analysis and has several patents in this field. TŠ, HD, ACi, FV and OG are employees of Genos Glycoscience Ltd.Funding StatementGlycosylation analysis was performed in Genos Glycoscience Research Laboratory and partly supported by the European Union’s Horizon 2020 grants Backup (grant# 777090), European Structural and Investment Funds IRI grant (#KK.01.2.1.01.0003), Centre of Competence in Molecular Diagnostics (#KK.01.2.2.03.0006) and Croatian National Centre of Research Excellence in Personalized Healthcare grant (#KK.01.1.1.01.0010). Bariatric research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Gastroenterology and Mucosal Immunity Theme to CVA-C and VLG, Oxford Biomedical Research Centre Diabetes and Metabolism theme for JWT, MRC programme grant to JWT (ref. MR/P011462/1), the NIHR Research Capability Funding to VLG and AG, the Wellcome Trust (101734/Z/13/Z) to AG. NJD is supported by a University of Oxford Novo Nordisk Clinical Research Fellowship. TwinsUK received funding from the Wellcome Trust European Community’s Seventh Framework Programme (FP7/2007-2013 to TwinsUK); the National Institute for Health Research (NIHR) Clinical Research Facility at Guy’s & St Thomas’ NHS Foundation Trust and the Nottingham NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. CM is funded by the MRC AimHy (MR/M016560/1) project grant and by the Chronic Disease Research Foundation.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and analysed during the current study are available from the corresponding author on reasonable request.